Breaking News Instant updates and real-time market news.

VERI

Veritone

$4.50

-0.23 (-4.86%)

, BBBY

Bed Bath & Beyond

$12.26

0.47 (3.99%)

18:45
01/09/19
01/09
18:45
01/09/19
18:45

Fly Intel: After Hours Movers

UP AFTER EARNINGS: Veritone (VERI) up 22.4%... Bed Bath & Beyond (BBBY) up 16.7%... Zumiez (ZUMZ) up 8.1% after raising Q4 earnings outlook... KB Home (KBH) up 3.5%. ALSO HIGHER: Union Pacific (UNP) up 1.8% after updating FY18 operating revenue outlook.. Constellation Brands (STZ) up 1.2% after upgrade at Guggenheim. DOWN AFTER EARNINGS: Simulations Plus (SLP) down 6.8%... Richardson Electronics (RELL) down 6.0%... WD-40 (WDFC) down 2.1%.

VERI

Veritone

$4.50

-0.23 (-4.86%)

BBBY

Bed Bath & Beyond

$12.26

0.47 (3.99%)

ZUMZ

Zumiez

$21.26

0.14 (0.66%)

KBH

KB Home

$21.90

0.78 (3.69%)

UNP

Union Pacific

$150.36

-0.4 (-0.27%)

STZ

Constellation Brands

$150.91

-21.38 (-12.41%)

SLP

Simulations Plus

$20.35

-0.07 (-0.34%)

RELL

Richardson Electronics

$8.36

0.12 (1.46%)

WDFC

WD-40

$183.70

4.31 (2.40%)

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 10

    Jan

  • 14

    Jan

  • 14

    Jan

  • 17

    Jan

  • 18

    Jan

  • 24

    Jan

  • 18

    Feb

VERI Veritone
$4.50

-0.23 (-4.86%)

12/21/18
DADA
12/21/18
NO CHANGE
Target $12
DADA
Buy
Veritone likely to trade a bit lower on Apis pulling bid, says DA Davidson
DA Davidson analyst Thomas Diffely believes Veritone shares will likely trade a bit lower on news that Apis Capital Management has withdrawn its offer to acquire the company for $10.26 per share, but he also believes the recent decline in stock price and significant discount versus the offer price show there was already "plenty of deal skepticism." He continues to value Veritone as an independent company and keeps a Buy rating and $12 price target on the stock based on future earnings potential, Diffely said.
11/14/18
CHLM
11/14/18
NO CHANGE
Target $14
CHLM
Buy
Veritone price target lowered to $14 from $22 at Craig-Hallum
Craig-Hallum analyst Chad Bennett lowered his price target for Veritone to $14 from $22, while reiterating a Buy rating on the shares. The analyst notes that the stock is currently near all-time lows, but believes further execution on revenue growth and EBITDA improvement should provide meaningful upside to investors from current levels.
12/11/18
ROTH
12/11/18
NO CHANGE
Target $15
ROTH
Buy
Likeliness of Apis acquiring Veritone low for now, says Roth Capital
Roth Capital analyst Darren Aftahi notes that Apis Capital's PE group submitted an offer to take Veritone private in an all-cash deal for about $10.26/share. It appears Veritone has been hesitant to negotiate with Apis, which suggests the likeliness of a transaction is low, he contends. The analyst continues to look for expansion of Veritone's platform in new product use cases and cash burn mitigation as catalysts to drive shares higher. Aftahi reiterates a Buy rating and $15 price target on the stock.
11/13/18
11/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Veritone (VERI) upgraded to Neutral from Sell at B. Riley FBR with analyst Sameet Sinha citing the company's better than expected Q3 results and increased business visibility for the upgrade to Neutral. 2. Nvidia (NVDA) upgraded to Positive from Neutral at Susquehanna while Xilinx (XLNX) was upgraded to Positive from Neutral. 3. Koppers Holdings (KOP) upgraded to Buy from Neutral at Monness Crespi. 4. Southwestern Energy (SWN) upgraded to Neutral from Underperform at BofA/Merrill with analyst Doug Leggate saying U.S. natural gas prices have lifted by 50c in the past 3 weeks and $1 since September as cold weather forecasts have been updated. 5. SailPoint (SAIL) upgraded to Buy from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BBBY Bed Bath & Beyond
$12.26

0.47 (3.99%)

01/02/19
LOOP
01/02/19
NO CHANGE
Target $12
LOOP
Hold
Loop Capital says Bed Bath Beyond, Amazon price gap widens to historical levels
Loop Capital analyst Anthony Chukumba kept his Hold rating and $12 price target on Bed Bath & Beyond (BBBY), saying his periodic pricing study demonstrated that the gap between the company and Amazon.com (AMZN) has widened back to its "historical level". The analyst sees this as a likely negative for the former, but also notes that that discounting has been a challenge in maintaining its gross margins. Chukumba maintains his forecasts on Bed Bath results ahead of next week's earnings, adding that while its stock trades at a discount to historical average levels, the 6.5-times expected forward earnings multiple is "in line" with other "secularly challenged specialty hardlines retailers."
11/08/18
SBSH
11/08/18
NO CHANGE
Target $13
SBSH
Sell
Bed Bath & Beyond activist probability low, 'screens well' for LBO, says Citi
Citi analyst Kate McShane reiterated a Sell rating on Bed Bath & Beyond shares, noting that the company has faced and continues to face significant challenges despite having enacted a number of changes in recent years. She views activist involvement or an LBO as a low probability given the number of challenges faced, but added that Bed Bath "has always screened well" as an LBO candidate. In a leveraged buyout scenario, the company could cut the dividend, shut down stores and create a smaller store format as a private company, McShane said.
10/02/18
LOOP
10/02/18
NO CHANGE
Target $15
LOOP
Hold
Bed Bath & Beyond pricing gap with Amazon narrowed in August, says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Hold rating and $15 price target on Bed Bath & Beyond (BBBY), saying his channel checks indicate a further narrowing of the pricing gap with Amazon (AMZN). The analyst notes the gap in August has shrunk to 13.6% on average vs. 16.9% in July, but also warns that given its position as the "most dynamic retailer" in the U.S. in terms of pricing, Amazon can "quickly and easily lower prices if top-line growth underperforms".
10/01/18
ARGS
10/01/18
DOWNGRADE
ARGS
Hold
Bed Bath & Beyond downgraded to Hold from Buy at Argus
Argus analyst Christopher Graja downgraded Bed Bath & Beyond to Hold after lowering his earnings estimates to reflect on ongoing gross margin pressure, declines in store traffic and spending on systems and consultants. The disappointing Q2 results amid a very strong retail environment is a concern, Graja tells investors in a research note. The analyst is no longer confident in management's ability to focus on the company's long-term objectives.
ZUMZ Zumiez
$21.26

0.14 (0.66%)

09/25/18
DADA
09/25/18
INITIATION
Target $29
DADA
Neutral
Zumiez initiated with a Neutral at DA Davidson
DA Davidson analyst John Morris initiated Zumiez with a Neutral rating and a price target of $29, saying that the target's implied valuation puts it "in-line with the long-term growth rate of 15% and the midpoint of its historical trading range". The analyst adds that while the company's growth potential thesis remains intact, the valuation of the stock "adequately reflects" its positive opportunities. Morris further notes that Zumiez U.S. market is nearing maturity and also sees Q3 comps starting to lap its recent improvements.
10/25/18
JEFF
10/25/18
INITIATION
Target $28
JEFF
Buy
Zumiez initiated with a Buy at Jefferies
Jefferies analyst Janine Stichter started Zumiez with a Buy rating and $28 price target. The recent selloff "presents an attractive entry point to own a quality retailer at near 5-year trough multiples," Stichter tells investors in a research note. She believes Zumiez will continue to be a "key beneficiary of a strong branded apparel cycle."
10/25/18
10/25/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Seadrill (SDRL) initiated with a Buy at BTIG. 2. Resideo (REZI) initiated with an Outperform at Oppenheimer. 3. Magnolia Oil & Gas (MGY) initiated with an Overweight at MUFG. 4. Athenex (ATNX) initiated with a Buy at Ladenburg. 5. Zumiez (ZUMZ) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/07/18
DADA
12/07/18
NO CHANGE
Target $20
DADA
Neutral
Zumiez price target lowered to $20 from $29 at DA Davidson
DA Davidson analyst John Morris lowered his price target on Zumiez to $20, saying that while the company topped Q3 earnings consensus, the beat was attributable to a lower tax rate. The analyst further cites Zumiez's Q4 outlook coming below consensus, even as he notes the management's history of providing conservative outlook at a time of uncertain and promotional holiday retail environment. Morris believes that Zumiez is "benefiting from a '90s-like fashion trend" suitable for its product line-up, but also remains cautious with a maintained Neutral rating until he sees "more conviction" in its long-term earnings power.
KBH KB Home
$21.90

0.78 (3.69%)

11/15/18
BTIG
11/15/18
NO CHANGE
Target $18
BTIG
Sell
KB Home price target lowered to $18 from $21 at BTIG
BTIG analyst Carl Reichardt lowered his price target on KB Home to $18 and kept his Sell rating after the company's updated guidance on its annual analyst call with reduced expectations for Q4 and FY19 along with below-consensus view of Q1. The analyst states that KB Home's absorption comps are set to become "significantly more challenging", and while the company relies on California to be the driver of overall community growth, he expects the demand conditions in the state to remain challenging amid affordability constraints. Reichardt also lowers his FY18 EPS view to $2.72 from $2.86 following yesterday's update.
11/15/18
WELS
11/15/18
NO CHANGE
Target $30
WELS
Outperform
KB Home price target lowered to $30 from $35 at Wells Fargo
Wells Fargo analyst Stephen East lowered his price target for KB Home to $30 from $35 as the company's strategic progress update was "hijacked" by disappointing orders decline. The analyst reiterates an Outperform rating on the shares.
11/15/18
LEHM
11/15/18
NO CHANGE
Target $21
LEHM
Equal Weight
KB Home price target lowered to $21 from $27 at Barclays
Barclays analyst Matthew Bouley lowered his price target for KB Home to $21 citing the company's Q4 and fiscal 2019 guidance reductions as well as a "sharp" 14% contraction in year-over-year orders disclosed through the first 10 weeks of Q4. The "near-term absorption softening" leaves uncertainty around how much growth the community ramp can drive, Bouley tells investors in a research note. The analyst keeps an Equal Weight rating on the shares.
11/15/18
11/15/18
DOWNGRADE

Neutral
KB Home downgraded to Neutral on market deterioration at BofA/Merrill
As previously reported, BofA/Merrill downgraded KB Home to Neutral from Buy and lowered its price target to $24 from $26. Analyst John Lovallo said KB Home lowered its FY19 financial outlook to reflect market difficulties that have intensified over the past several weeks. KB Home's exposure to higher priced markets remains an overhang and a lower multiple is warranted given deteriorating market sentiment and absorption risk, Lovallo wrote in a note to investors.
UNP Union Pacific
$150.36

-0.4 (-0.27%)

01/08/19
SPHN
01/08/19
NO CHANGE
Target $170
SPHN
Overweight
Stephens says Vena hire should ease concerns of those skeptical of Union Pacific
After Union Pacific (UNP) announced that it has named Jim Vena, who most recently served as EVP and COO at Canadian National (CNI), as its new Chief Operating Officer, Stephens analyst Justin Long said he views the hiring positively and believes it will help ease concerns of those who were skeptical about Union's ability to successfully execute its new plan. Long, who said Vena's hiring increase his confidence that Union Pacific can deliver on its new Unified Plan 2020, keeps an Overweight rating and $170 price target on the stock, which he maintains as his 2019 Best Idea.
01/08/19
01/08/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. VMware (VMW) resumed with a Buy at Citi. 2. CSX (CSX) and Kansas City Southern (KSU) were initiated with an Overweight at Atlantic Equities, while Union Pacific (UNP) was initiated with a Neutral. 3. First Solar (FSLR) and TerraForm Power (TERP) were initiated with an Overweight at Barclays, Covanta (CVA) and Azure Power (AZRE) were initiated with an Equal Weight, and SunPower (SPWR) was initiated with an Underweight. 4. At Home Group (HOME) initiated with a Buy at Monness Crespi. 5. Chemours (CC) initiated with a Buy at HSBC. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/19
01/08/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Voya Financial (VOYA) upgraded to Buy from Neutral at Goldman Sachs analyst Alex Scott saying the company is well positioned to manage through the pullback in equity markets and still hit its targets of 10%-plus earnings growth. 2. Cheesecake Factory (CAKE) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Vaccaro citing better than expected industry sales. 3. Union Pacific (UNP) upgraded to Outperform from Market Perform at Cowen, to Outperform from Sector Perform at RBC Capital and Scotiabank, and to Buy from Neutral at Seaport Global. 4. Monster Beverage (MNST) upgraded to Buy from Hold at SunTrust with analyst William Chappell saying after the recent declines in input costs and the "successful U.S. pricing actions," consensus expectations for the stock are too low, while the concerns over its partnership with Coca-Cola (KO) and challenges around growth in China are "overblown." 5. Molina Healthcare (MOH) upgraded to Overweight from Neutral at both JPMorgan and MUFG. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/19
01/08/19
UPGRADE
Target $165

Buy
Seaport Global upgrades Union Pacific to Buy after COO hiring boosts confidence
As previously reported, Seaport Global analyst Mark Levin upgraded Union Pacific to Buy from Neutral after the company announced that it had hired Jim Vena as COO to help implement precision scheduled railroading. "While Vena may not be Hunter Harrison," the pioneer of PSR, his addition at Union Pacific significantly increases the likelihood of a successful transformation to PSR, Levin tells investors. Greater investor confidence that Union will eventually reach a 55%-60% operating ratio should help propel the stock, added Levin, who set a $165 price target on the shares.
STZ Constellation Brands
$150.91

-21.38 (-12.41%)

01/07/19
HSBC
01/07/19
UPGRADE
Target $206
HSBC
Buy
HSBC upgrades Constellation Brands to Buy on valuation despite risks
HSBC analyst Carlos Laboy upgraded Constellation Brands to Buy from Hold with an unchanged price target of $206. The company is facing increasing risks from water permit uncertainty, a possible vote to shut down the Mexicali brewery, and new national water laws, Laboy tells investors in a research note. The analyst says that despite these risks, he upgrades Constellation to Buy on valuation. His "base case" implies 28% share upside.
01/09/19
JEFF
01/09/19
NO CHANGE
Target $269
JEFF
Buy
Constellation Brands selloff overdone after guidance lowered, says Jefferies
Jefferies analyst Kevin Grundy said he expects Constellation Brands shares to trade lower today following the company's "lower-quality" Q3 earnings beat and FY19 guidance lowering, though he believes the pre-market reaction appears to be overdone and would be a buyer amid the early weakness. While Constellation Q3 "certainly was not clean," consumer demand in the beer business remains very healthy and the stock's valuation "has reached washed out levels," according to Grundy, who keeps a Buy rating and $269 price target on the shares.
01/09/19
GUGG
01/09/19
UPGRADE
GUGG
Neutral
Constellation Brands upgraded to Neutral from Sell at Guggenheim
Guggenheim analyst Laurent Grandet upgraded Constellation Brands to Neutral saying the stock's risk/reward is more balanced following today's post earnings selloff.
01/07/19
JEFF
01/07/19
UPGRADE
JEFF
Buy
Coca-Cola European Partners upgraded to Buy from Hold at Jefferies
Jefferies analyst Kevin Grundy upgraded Coca-Cola European Partners (CCEP) to Buy with an increased price target of EUR 49. The analyst sees inflecting trends, capital deployment optionality and upside to consensus estimates for the company. His top pick in Consumer Products for 2019 is Constellation Brands (STZ).
SLP Simulations Plus
$20.35

-0.07 (-0.34%)

09/05/18
09/05/18
NO CHANGE

Simulations Plus extends funded GastroPlus research collaboration with the FDA
Simulations Plus has entered into a one-year funded extension to its previous cooperative agreement with the FDA to further develop and validate the mechanistic Ocular Compartmental Absorption and Transit model in GastroPlus.
RELL Richardson Electronics
$8.36

0.12 (1.46%)

WDFC WD-40
$183.70

4.31 (2.40%)

07/11/18
RILY
07/11/18
NO CHANGE
Target $152
RILY
Neutral
WD-40 price target raised to $152 from $135 at B. Riley FBR
B. Riley FBR analyst Liam Burke raised his price target for WD-40 to $152 following the company's Q3 results. Maintenance product sales growth drove better than expected earnings, Burke tells investors in a research note. He keeps a Neutral rating on WD-40.
12/07/18
DADA
12/07/18
INITIATION
Target $209
DADA
Buy
WD-40 initiated with a Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated WD-40 with a Buy rating and a price target of $209. The analyst cites the company's targeting of sales reaching $700M in FY25, which implies an annualized growth of about 8% and represents a step-up from its 2%-5% historical rate. Weiser also notes WD-40's EBITDA margin forecast of 25% vs. 22% in FY18 along with its FY19 guidance of $4.51-$4.58 being achievable if oil prices can stay below $60 a barrel for another two months. Lastly, the analyst cites the company's expectations of a next "margin-accretive major innovation" announcement in March of 2019.

TODAY'S FREE FLY STORIES

ETFC

E-Trade

$47.45

0.88 (1.89%)

17:33
02/17/19
02/17
17:33
02/17/19
17:33
Conference/Events
E-Trade to hold Education Day »

Education Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

PFE

Pfizer

$42.41

0.45 (1.07%)

12:56
02/17/19
02/17
12:56
02/17/19
12:56
Hot Stocks
Pfizer, EMD Serono announce publication of Phase 3 data for BAVENCIO plus INLYTA »

Merck KGaA, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

MRK

Merck

$79.84

0.9 (1.14%)

, PFE

Pfizer

$42.41

0.45 (1.07%)

12:48
02/17/19
02/17
12:48
02/17/19
12:48
Hot Stocks
Merck presents results from Phase 3 KEYNOTE-426 study »

Merck (MRK) announced…

MRK

Merck

$79.84

0.9 (1.14%)

PFE

Pfizer

$42.41

0.45 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

  • 18

    May

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

12:42
02/17/19
02/17
12:42
02/17/19
12:42
Hot Stocks
Aveo Pharmaceuticals presents TIVO-3 trial topline results »

Aveo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.